Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13698: Variant p.Leu458His

Voltage-dependent L-type calcium channel subunit alpha-1S
Gene: CACNA1S
Feedback?
Variant information Variant position: help 458 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Histidine (H) at position 458 (L458H, p.Leu458His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 458 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1873 The length of the canonical sequence.
Location on the sequence: help VILIVALNTLSIASEHHNQP L WLTRLQDIANRVLLSLFTTE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         VILIVALNTLSIASEHHNQPLWLTRLQDIANRVLLSLFTTE

Mouse                         VILIVALNTLSIASEHHNQPLWLTHLQDVANRVLLTLFTIE

Rat                           VILIVALNTLSIASEHHNQPLWLTHLQDVANRVLLALFTIE

Rabbit                        VILIVALNTLSIASEHHNQPLWLTHLQDIANRVLLSLFTIE

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1873 Voltage-dependent L-type calcium channel subunit alpha-1S
Topological domain 452 – 462 Extracellular
Repeat 418 – 664 II



Literature citations
Cloning of the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).
Hogan K.; Powers P.A.; Gregg R.G.;
Genomics 24:608-609(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS HIS-458 AND ASP-1840; Malignant-hyperthermia susceptibility is associated with a mutation of the alpha-1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.
Monnier N.; Procaccio V.; Stieglitz P.; Lunardi J.;
Am. J. Hum. Genet. 60:1316-1325(1997)
Cited for: SEQUENCE REVISION; VARIANT MHS5 HIS-1086; VARIANTS HIS-458 AND CYS-1539;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.